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FORWARD

This thesis presents data collected during my master’s program. The data collected and
presented here describes the role of resident tissue macrophages in the peripheral nervous system with
an emphasis on their contribution to chronic pain states. The phenotype of resident tissue macrophages
was poorly established especially in context to more widely known blood monocytes and microglia.
Further we demonstrate the transient changes in resident tissue macrophages in the dorsal root ganglia
were established, highlighting the up regulation of extra cellular proteins such as MHC Class II and
CD39. This work will be submitted to a peer review journal upon completion of a few follow up
studies.
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ABSTRACT

POTENTIAL ROLE OF DRG MACROPHAGES IN CHRONIC PAIN
by
Scott Scarneo
University of New England, May, 2017

Persistent pain remains a significant burden on the US healthcare system with more than 100
million patients experiencing persistent pain annually. Complex etiology coupled with functional
plasticity of cells involved often results in a chronic health concern with limited treatment modalities.
To date, most work aimed at describing neuro-immune interactions in pain focuses on the site of injury,
leaving the functional significance of resident tissue macrophages in the dorsal root ganglia largely
unexplored in both uninjured and peripheral injury states. Here, we systematically evaluate the
phenotype of naïve DRG resident tissue macrophages and compare to naïve spinal microglia and bone
marrow derived monocytes. We report the upregulation of CD39 and MHC Class II by DRG
macrophages 24 and 72 hours following distal insult in multiple models of inflammatory pain. Further,
we demonstrate functional changes induced in DRG macrophages in response to peripheral injury by
profiling the cytokine proteome: DRG expression of 111 cytokines were evaluated with and without
injury. Taken together, these data suggest that resident tissue macrophages actively respond to distant
injury stimuli with functional changes and may influence nociception via neuro-immune
communication.
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CHAPTER 1
INTRODUCTION
Chronic pain remains a prevalent health concern. Despite affecting up to 100 million patients
in the U.S. alone, the underlying disease mechanism still remains relatively unresolved [1]. One
underlying mechanism contributing to chronic pain may be the synergistic communication between
immune cells and neurons. Interactions amid pain and inflammation have established for centuries,
however mechanisms of neuro-immune interaction in response to injury remain unclear [2]. Current
therapeutics aimed at regulation of inflammation, such as non-steroidal anti-inflammatory drugs
(NSAIDs), often fail to alleviate severe pain and are short acting [3]. Understanding how specific
genetic, psychological, and physiological properties contribute to the development of chronic pain will
aid in the development of novel non-opioid compounds [4].

Neuronal Pathology of Pain
Conscious perception of nociception is essential for life, allowing human beings to detect
harmful stimuli [5]. Under normal circumstances, pain is indicative of a potentially harmful stimulus
directly affecting tissue. Nociceptors, specialized receptors present on nerve endings, detect thermal,
chemical, and mechanical stimuli within their cutaneous and visceral targets [6]. Specific nerve fibers
within the peripheral nervous system (PNS) transmit pain: class A () myelinated fibers and
unmyelinated class C fibers. Class A () fibers are responsible for carrying sharp and fast initial pain
transmissions, whereas class C fibers aid in the transmission of duller and slower pain signals [7].
Transmission of these signals, nociception, is accomplished via synapse of primary afferent neurons
with secondary afferent axons in the dorsal horn of the spinal cord. The signal then continues up the
contralateral spinothalamic tract to synapse in the ventroposterolateral (VPL) nucleus and
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ventroposteroinferior (VPI) nucleus of the thalamus with conscious perception of pain occurring with
synapse in the primary somatosensory cortex [9,10].
In some cases, pain persists even after the removal of noxious stimuli and the return to normal
cellular physiology [8]. The term neuropathic pain is defined as pain which derives from a direct
consequence of damage or disease to the somatosensory system [9]. It remains to be determined
whether neuropathic pain and chronic pain are one and the same or distinct subclasses of persistent
painful conditions. However, the complexity of these conditions and urgency for development of novel
non-opioid therapeutics is consistently agreed upon [8]. Although persistent pain has been documented
clinically for many years, the exact cause and pathology continue to be elusive. This in part arises
from the plasticity of the primary afferent neurons, in which cellular processes are modified in
response to inflammation or direct nerve damage [10]. Hyperalgesia, an increased sensitivity to pain
stimulus, is an often observed clinical aspect of persistent pain. Primary hyperalgesia occurs directly
at the site of injury within tissue and may be specifically dependent on persistent inflammatory
processes, whereas secondary hyperalgesia is mediated a distance from the injury with unknown
immune contribution [11]. Changes in neuronal transmission of pain may develop into alloydnia, a
condition in which a previous innoculous stimulis is perceived as noxious under persistent pain states
[12].
Receptors and ion channels expressed on neuronal cell surface play a large role in the
transmission of noxious stimuli within the pain pathway and expression characteristics aid in
distinguishing one neuron from another in their biology and transmissory ability [13]. For example,
the transient receptor potential (TRP) family of ligand-gated ion channels are a class of receptors
frequently expressed on nociceptor neurons that respond to temperature [14] . TRP channel expression
isn’t the only distinguishing mark of nocicpetors however; there are other varying sodium channels
and neuropetptides which help discern neuronal sub type and function [15].
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G coupled protein receptors (GPCRs) are another group of receptors with high levels of
neuronal expression, though many other tissues express GPCRs as well. The diverse family of GPCRs
all share a characteristic 7 transmembrane passing protein domain and play an important role in
transducing extracellular signals. Intracellular G protein signaling is induced by binding of a plethora
of ligands including hormones, neurotransmitters and cytokines to their respective GPCR [16].
Following extracellular binding, intracellular G protein subunits , , and  are further activated
through GTP/ GDP exchanges induced by conformational changes in the corresponding GPCR upon
ligand binding. Ligand binding and subsequent G protein initiation lead to a wide variety of
downstream intracellular changes dependent on the specific combinations of G protein subunits
coupling with the GPCR [17].
Major GPCR classifications
Gs coupled GPCRs serve to increase neuronal excitability by increasing adenylyl cyclase
activity downstream of the s subunit [18]. Elevated cAMP levels within the cytoplasm cause
activation of protein kinase A (PKA), an immediate effector kinase capable of modulating activation
status of other downstream effectors. PKA also regulates transcriptional activity as well as modulates
cell membrane compositions [19].
Contrary to Gs -coupled receptors, Gi/o –coupled receptors inhibit effects of
neurotransmitters within neurons. Gi/o subunit activity inhibits adenylyl cyclase, directly opposing
Gs signaling activity [20]. In addition to these effects, Gi/o signal cascades inhibit neurotransmitter
release in the synaptic cleft. Reduction in postsynaptic neurotransmitter availability subsequently
decreases signaling between neurons; within sensory neurons the result may include increased pain
thresholds by reducing flux through afferent signaling pathways.
Finally, Gq/11 –coupled receptors biochemical pathway operates through phospholipase C
Beta (PLC). Down stream effectors include phosphatidylinositol-4,5-bisphosphate PIP2 leading to
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(IP3) initiated (Ca2+) release from intracellular calcium storages [21].Alternatively, Gq/11 activation
activates diacylglycerol (DAG) which may also aid in the increase in intracellular calcium levels.
Heightened levels of calcium within the cytoplasm cause activation of protein phosphatase calcineurin
further facilitating stimulating the NFAT transcriptional factors [22].
Purinergic receptors
Purinergic receptors are a specialized family of GPCRs of particular importance. P2 receptors
are expressed primarily on neurons that respond to extracellular signals such as ATP as well as other
purine and pyrimidine nucleotides. Studies have shown both P2X and P2Y receptors participate in the
processing of sensory information including pain [23].
Previous work demonstrates via RT-PCR analysis that the mRNAs of three P2Y receptors,
P2Y12, P2Y13 and P2Y14, are upregulated 4 days following CFA injection in murine dorsal hind paw
[24]. These findings suggest modulation of P2Y expression and potentially functional response to
peripheral injury. Further work shows that P2Y12 receptor expression in lumbar ganglia is limited to
unmyelinated neurons within the sensory ganglia whereas expression of P2Y13, and P2Y14
expression are seen on both myelinated and unmyelinated neuronal cell bodies [24] . P2Y12, P2Y13,
and P2Y14 receptors signal through the Gi/o signaling pathway. It stands to reason then that these
receptors may play a role in modulating pain response in murine peripheral nerve injury models.
Indeed, unpublished data collected in the Molliver laboratory have shown that treatment with P2Y
agonists exert anti-nociceptive responses following forskolin. Thus, P2Y signaling may be of
particular importance in restoring neuronal cell homeostasis following nerve injury.
Neuronal support: satellite glial cells
Satellite glial cells (SGC’s) tightly adhere and wrap around neuronal cell bodies in ganglia,
and can mediate cell signaling. These specialized Schwann cells are primarily found within sensory,
sympathetic and parasympathetic ganglia [25]. Originally believed to have complex processes similar
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to astrocytes in the brain, it is now known these cells are laminar in morphology with often more than
one cell interacting with a sensory neuron [26]. Close proximity of neurons and satellite glial cells, 20
nm apart, provide the potential for robust proximal signaling between the two [23]. Signaling is further
enhanced by microvilli which extend from the neuronal cell surface into the extracellular space, and
invaginations of the satellite glial cells in some cases increasing the neuronal cell surface by up to 3040% and the interactions between satellite glial cells and neurons [27].
In addition to their close spatial relation to neuronal cell bodies, it has also been demonstrated
that satellite glia share the ability to communicate through intercellular messengers including ATP
[28]. The presence of purinergic receptors for ATP, as well as other neurotransmitter receptors, have
been explored on satellite glia data suggest neuronal communication with satellite glia [29]. Further
work has implicated nitric oxide as a critical mediator of signal transduction between neurons and
satellite glial cells. In naïve states 5% of sensory neurons express neuronal nitric oxide synthase
(nNOS), however under pathological conditions expression is markedly upregulated, leading to
subsequent elevated NO levels in neurons [30]. Further, Aoki et al. demonstrated high levels of cyclic
GMP (cGMP), which is upregulated in response to NO, in satellite glial cells[32]. Concurrent elevation
of arginine levels found by the same group suggests existence of an inhibitory feedback loop [31].
These discoveries led to the proposal of a mechanism of signal transduction in which neurons, under
pathological stress, upregulate nNOS activity and its product NO, which signals in paracrine fashion
to upregulate cGMP signaling in satellite glial cells [31].

Relevant immune cells and inflammatory contribution to pain signaling
Macrophages
Macrophages are critical mediators of the innate immune response. While traditionally
macrophages have been defined as originating from bone marrow derived monocytes, recent work by
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Perdiguero et al. in 2014 demonstrates that populations of yolk sac derived tissue resident
macrophages are distinct from macrophages arising from bone marrow derived monocytes [32]. Bone
marrow derived monocytes are continuously regenerated in bone marrow throughout adulthood and
circulate in the blood stream, activating into macrophages only upon stimulation by extracellular
factors such as pathogen associated molecular patterns (PAMPs) or damage associated molecular
patterns (DAMPs) [33, 34]. Conversely, tissue resident macrophages differentiate in the prenatal
period and persist throughout adulthood in the tissue of origin [35]. It is still unclear whether blood
monocytes are able to replenish tissue resident macrophage populations on an as needed basis [36].
Both bone marrow derived and tissue resident macrophages mediate inflammatory response, acting as
the cellular bridge between innate and adaptive response by taking on the role of major cytokine and
chemokine manufacturing sites and by exhibiting the ability to upregulate and express the antigen
presentation complex MHC Class II [37].
An additional macrophage classification system is useful in delineating specific cell functions.
M1 macrophages contribute to the pro-inflammatory response whereas M2 macrophages are trophic
or anti-inflammatory [38]. The dichotomy is derived from the distinct metabolic processing of
arginine. M1 macrophages convert arginine to NO, a reactive oxygen species (ROS), through
inducible nitric oxide synthase iNOS whereas metabolic processing of arginine by arginase in M2
macrophages inhibits iNOS activity by out competing substrate availability [39, 40]. This reduces the
inflammatory response through reduction of ROS in the cell [38]. These phenotypic classifications are
not mutually exclusive but rather they highlight the complexity of macrophages in that macrophages
are not terminally differentiating cells, differentiated phenotypes are modifiable by alterations in
microenvironment and significant crossover exists between the M1 and M2 phenotypes [41].
Macrophages isolated from mammalian tissues are notoriously difficult to identify due to the
overlap of expression of many significant cell surface proteins between various leukocytes. A number
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of parameters are described in chapter II and chapter III to define macrophage or monocyte populations
or to exclude extraneous populations. For reference, a description of these markers is provided here.
CD11b- A common macrophage marker used to aid in delineating cell type is Cd11b. Cd11b, also
known as integrin alpha M (ITGAM), has been implicated in cell adhesion, migration, phagocytosis
and cell activation [42].The protein is a subunit of the greater heterodimeric (M - 2) protein known
as macrophage-1 antigen (Mac-1) with the common chain  2 or also known as cluster differentiation
molecule CD18 [43]. CD11b is not exclusive to macrophages and monocytes with expression
demonstrated on related leukocytes in the innate immune system including dendritic cells,
granulocytes and natural killer cells [42].
CD11c- an additional integrin, often used to identify dendritic cells. Similar to Cd11b, Cd11c is a
subunit of the heterodimeric protein in conjunction with  2 [44]. Although expression can often
overlap that of Cd11b, high expression has been found on dendritic cells in human and murine species,
thus CD11cmedium –high expressing Cd11b cells are often described as classical dendritic cells (cDC’s).
Expression has also been found on naïve alveolar macrophages at levels that mimic cDC’s [45].
CD103- Cluster of differentiation protein 103 is used in identification of a small subpopulation of
intestinal classical dendritic cells with expression ranging from 20-30% of total leukocyte population
in the intestinal track[45]. Hence, these cells are further characterized as CD103 + cDC’s. CD103+
cDC’s are also found in most connective tissues [46] .
CD115- Macrophage colony stimulating factor receptor or colony stimulating factor 1 receptor
(CSF1r; CD115) is a receptor found on the surface of macrophages and other innate immune cells
which acts as the receptor to the cytokine colony stimulating factor- 1 ligand [47]. This cytokine plays
a role in production, subsequent differentiation, migration, and function of macrophages.
CD169- Siglec-H or CD169 is a surface adhesion molecule found on macrophages which binds the
sialic acid residues on other cells [48]. Moreover, it has been seen that CD169 can adhere to red blood
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cells and thus is highly expressed in organs which filter blood such as the spleen [49]. Under pro
inflammatory states CD169 is upregulated on macrophages [50].
Ly6G- a neutrophil specific cell surface protein; allows distinction from other myeloid derived
leukocytes [51]. Ly6G is an extracellular protein expressed in a highly regulated fashion from
progenitor bone marrow cells throughout development and differentiation of neutrophils [52]. High
Ly6G expression in Cd11b+ cells is used to define neutrophil lineage cells.
Major histocompatibility complex class II (MHC Class II) expression occurs on immune cells capable
of presenting antigen to CD4 helper T cells, including macrophages, dendritic cells, and some B
lymphocytes [53]. This expression profile contrasts major histocompatibility complex class I (MHC
Class I) protein complexes, which are present on all mammalian cells with a nucleus and are viewed
as ‘self’ identifiers by effector immune cells including NK cells and CD8 cytotoxic T lymphocytes
[54]. MHC Class I recognition prevents inappropriate NK cell killing response and facilitates proper
activated CD8 T lymphocyte response by presenting self antigen on healthy self cells while stress
antigens or foreign antigens are complexed with MHC Class I on unhealthy self cells, thus allowing
immune response against invaded cells [55, 56]. Under healthy physiological conditions macrophages
exhibit MHC class I complexes much like other self cells, however upon stimulation by PAMPs or
DAMPs macrophages upregulate expression of MHC Class II membrane proteins [57]. In response to
foreign antigens macrophages phagocytize invaders and present protein fragments (antigens) via MHC
Class II complex [58]. Hence, MHC Class II expression is often correlated with antigen detection and
subsequent antigenic presentation to other immune cells, leading initiation of the adaptive immune
response.
CX3CR1- CX3C chemokine receptor 1, or fractalkine receptor, is a membrane bound protein involved
in adhesion and migration of mononuclear leukocytes [59]. Expression of this protein has been found
on macrophages, monocytes and microglia where its expression is often linked to cell survival [62].
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Additionally, in the central nervous system CX3CR1 expression on microglia has been found to play
a role in activation and migration of microglia to damaged regions of CNS where they may undergo
phagocytosis [60].
CD39- The ectonucleoside triphosphate diphosphohydrolase 1, E-NTPDase1 or cluster of
differentiation 39 (CD39), is an extracellular protein with an active domain open to the extracellular
milieu [61]. CD39 responds to extracellular purinergic signaling molecules, primarily ATP. CD39
mediates ATP availability by catalyzing the hydrolysis of ATP to AMP, which can be further
converted via CD73 into adenosine [62]. In some persistent pain states elevated levels of ATP have
been found in the DRG following peripheral injury [102]. Thus, macrophages may have the ability to
mediate purinergic signaling by modulation of available ATP/AMP substrate. Interestingly, adenosine
has been reported to dampen inflammatory response and allow pro inflammatory cells to return to a
more quiescent state [63]. Together, this data leads to the hypothesis that insufficient DRG
macrophage CD39 activity may contribute to persistent pain states by limiting flux through the
metabolic pathway of ATP to adenosine conversion.
CCR2- Expression of chemokine receptor-2 (CCR2) has been documented on macrophages,
monocytes as well as other migrating leukocytes [64]. This extracellular receptor for the ligand (CCL2) plays an important role in cell migration. Recent data suggest up regulation of the CCR2 ligand,
CCL2 in mRNA levels in DRG of peripherally injured rats [65].

Cd11b

CD11c

CD39

CD103

CD169

MHC II

CX3CR1

CCR2

Ly6G

Ly6C

Macrophages

++

+

+++

-

+

+++

+++

+

-

+

Monocytes

++

NK

+

-

+

+

+

++

-

++
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Neutrophils

+

-

-

-

-

-

NK

NK

+++

-

CD103+ cDC’s

+/-

+++

NK

+

NK

++

NK

NK

-

NK

cDC’s

+

+++

NK

-

NK

++

NK

NK

-

NK

Microglia

+

NK

+

-

NK

-

+

-

-

-

Table 1.1 – Expression of phenotypic lineage markers by leukocyte populations in mice.
*NK= Not currently known, or agreed upon

Macrophage expression of purinergic receptors
Macrophages have also been shown to express P2X and P2Y receptors. P2Y12, P2Y13, and to
a greater extent P2Y14 have been demonstrated. P2Y14 receptors act to inhibit adenylyl cyclase
activity, further inhibiting the production of cAMP [66] . The endogenous ligand for P2Y14 is UDPglucose- an important nucleotide sugar involved in glycotransferase reactions in glycogen metabolism.
Often found in the cytoplasm, UDP-glucose may also be transferred to the cell membrane and released
[67].
Cytokines involved in macrophage function
Cytokines, the most prevalent immune signaling molecules, act as intercellular messengers.
These small proteins usually less than 30 kDa in size mediate the carefully choreographed immune
response to foreign antigens and are loosely categorized as pro or anti inflammatory, however
significant overlap occurs depending on the full cytokine milieu [68, 69]. For context, cytokines
involved in macrophage differentiation and function are briefly described.
Pro-inflammatory cytokines polarize bone marrow derived monocytes or tissue resident macrophages
into pro-inflammatory effector cells, upregulating migration, phagocytosis and antigen presentation
[70]. Pro-inflammatory cytokines include IL-1a, IL-1ra, IFN-, CXCL2, CCL2. CD14, Tumor
necrosis factor  (TNF-), and granulocyte macrophage colony stimulating factor (GM-CSF). While
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these are primary members of the classical inflammatory milieu, many other inflammatory cytokines
have been documented [71, 72].
Trophic cytokines promote function of the trophic macrophage response important for wound healing.
A hallmark of trophic macrophage activity is reduced production of the reactive oxygen species nitric
oxide, which is a key component of inflammatory macrophage response. The reduction in NO
production can be attributed to substrate competition for the arginine precursor achieved by
upregulation of the enzyme arginase in M2 macrophages. The net effect of arginase upregulation is
significant reduction in arginine availability for activity of the inducible nitric oxide synthase enzyme
(iNOS). Cytokines supporting an trophic-inflammatory or trophic macrophage response include IL-4,
IL-10, Il-13,serepin E1, MMP3 and TGF- [73]. These important mediators of the immune system
initiate the return to homeostasis once the pro-inflammatory stimulus has been resolved and allow for
tissue repair to begin [74] .
Central Nervous System- immune interactions
The discovery of microglial cells by Franz Nissi shed light on the presence of immune entities
in the central nervous system [75]. Similar to macrophages in the periphery, microglia act as first
responders to injury in the central nervous system by quickly mobilizing and differentiating into
functional states reactive to CNS insult [76]. Microglia are capable of polarization rapidly and with
high efficiency into pro or trophic-inflammatory phenotypes dependent on extracellular stimuli. Due
to their dichotomous nature, tight regulation of microglial activation is needed to prevent unwanted
damage in central nervous tissue. Microglial activation is primarily mediated through receptors where
either of two categories may be received: “off” and “on” signals [77]. The “off” signal inhibits
potentially damaging inflammatory activation. “Off” receptors include CD200R, as well as P 1A3
which tonically retain the muted state of microglial cells [78]. “On” receptors include purinergic
receptors such as P1 adenosine receptors, P2 ATP receptors, as well as receptors for advanced
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glycation end products (RAGE) and others [79].In microglia, the existence and expression of P2X4,
P2X7, P2Y2, P2Y6 and P2Y12 have been previously investigated [80]. Studies have shown that
intrathecal injection of ATP stimulates microglia and initiates mechanical hypersensitivity as well as
release of brain derived neurotrophic factor (BDNF) [81]. Overall, regulation of microglial activation
plays a critical role in CNS injury response.
Peripheral nervous system- immune interactions.
Previous research has demonstrated some neuro-immune interactions in the periphery. In 1993,
Maves and colleagues were able to evoke neuropathic pain in the absence of direct peripheral nerve
injury by transplanting chromic gut sutures proximal to the sciatic nerve, leading to immune response
and subsequent neuropathy [82]. These data provided the initial suggestion that neuropathic pain may
be mediated at least in part by the immune system and that cross cell communication may be taking
place. Further studies have shown neuronal communication with immune cells through
neurotransmitters [83]. Research conducted by Pacheo, et. al. highlight the role of neurotransmitter
receptors, specifically dopamine receptors (DAR’s), in immune response [84]. To date five DAR have
been identified and are neuronal GPCR’s primarily activated through endogenous dopamine and
analogs [89]. Interestingly, all five dopamine receptors have been reported to also be expressed on T
cells. Findings indicate that of the five, only one, D3R, promotes inflammatory T cell stimulation.
Investigation of the other four DAR’s have shown they play a critical role in the induction of inhibitory
signals. D3R signaling activation promotes production and secretion of IFN while also inhibiting IL10 and IL-4 synthesis in T cells [84]. Evidence of leukocyte response to neurotransmitters may help
elucidate the means by which the immune system reacts to nerve tissue damage and signaling.
Likewise, research has shown that microglia cells are able to produce and secrete neurotransmitters
[84].
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The complex interactions between immune cells and neurons remain widely unknown,
however recent data suggests that macrophages may be involved in the development of persistent pain
[85]. We have confirmed the existence of resident macrophages in the dorsal root ganglia (DRG) of
naïve mice of multiple strains; these results are detailed in chapter II. We further explore the function
of tissue resident macrophages in sensory ganglia in subsequent chapters.
Overall, the role of macrophages in the peripheral nervous system has yet to be elucidated in
response to injury. In order to better understand the significance of resident macrophages in pain
response to peripheral nerve stimuli, we characterized the resident immune system in the DRG with
use of a transgenic mouse model. Initial findings of resident tissue macrophages were confirmed
through fluorescent imaging of eGFP expressing macrophages in the DRG of uninjured mice. Further,
we hypothesize that not only do resident tissue macrophages exist in the naïve ganglia but they respond
to neurons in persistent pain states though phenotype changes.
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CHAPTER 2
IMPACT OF RESIDENT TISSUE MACROPHAGES IN PERSISTENT PAIN

ABSTRACT
Pain is relevant to all clinical settings and a unifying force across specialties, though it remains
a burden on the US Health Care System. The development of persistent pain is preceded by
sensitization of central nociceptive pathways by mechanisms incompletely understood. Resident tissue
macrophages have been previously described in many tissue types, however peripheral nervous system
macrophages are less well described. Here we characterized the morphology and naïve phenotype of
resident tissue macrophages using flow cytometry and immunohistochemistry.

Phenotypically

distinct, compared to microglia and blood monocytes, >90% resident tissue macrophages in the dorsal
root ganglia express MHC Class II, CX3CR1, and CD39, with few <1% of cells positive for other
leukocyte phenotype markers including CD103, Cd11c, and Ly6G. Approximately 50% of resident
tissue macrophages express the monocyte chemokine attractant receptor CCR2. Inflammatory pain
model complete Freund’s adjuvant, show resident tissue macrophage response to peripheral injury by
exhibiting increased expression of CD39 and MHC Class II and an altered cytokine proteome profile,
suggesting altered macrophage function on detection of distant insult. This taken together indicates a
distinct phenotypic immune cell population in naïve dorsal root ganglia with a potentially distinct
functional value under persistent pain states.
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METHODS
Animals – All mice were housed and cared for in accordance of the University of New England
Institution Animal Care and Use Committee (IACUC). Mice were housed in a temperature and
humidity controlled facility under 12-hour light/dark cycle (lights on at 7 am) and access to food and
water ad libitum. All experiments were undertaken under approved protocol in accordance with the
institutional guidelines and the Guide for the Care and Use of Laboratory Animals. Csfr1-eGFP mice
were purchased from Jackson Laboratory and used for IHC and peripheral inflammatory injury (CFA)
as well as primary cell culture. Genotyping was performed by PCR using tail digests. Primers and
PCR conditions for Csfr1-eGFP were carried out under the following conditions 95C for 5:00
minutes, 30 cycles of 95C for 0:45s, 60C for 0:45s, 72C for 0:45s, followed by 72C for 5:00
minutes. PCR results were imaged on 1.5% agarose gel.
Transgenic Mice- B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J mice were purchased from Jackson Laboratory
and used for IHC and peripheral inflammatory injury (CFA) as well as primary cell culture.
Genotyping was performed by PCR using tail digests. Primers and PCR conditions for Csfr1-eGFP
were carried out under the following conditions 95C for 5:00 minutes, 30 cycles of 95C for 0:45s,
60C for 0:45s, 72C for 0:45s, followed by 72C for 5:00 minutes. PCR results were imaged on 1.5%
agarose gel. Primers listed in Appendix of Thesis.
Immunohistochemistry- Mice were perfused transcardically with Hanks Balanced Salt Solution
(HBSS) followed by 40 mLs of 4% paraformaldehyde (PFA). L3-5 DRG, spinal cord lumbar
enlargement, and glabrous and hairy hind paw skin were dissected out and cryo-protected overnight
in 30% sucrose, and embedded in Tissue-Tek Optimum Cutting Temperature (OCT) compound
(Thermo Fisher Scientific, Waltham, MA). Serial sections of DRG (12 m), were mounted on
Superfrost(+) slides (VWR, Radnor, PA). Cells were stained with antibodies against neuronal specific
enolase (NSE) – (Genetex Cat#GTX85462), GFAP- (Biolegend Cat#914501). Slides were incubated
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overnight at room temperature, washed 3 times for 15 minutes then stained with the following
secondary’s, Donkey anti Rabbit IgG – PE ( Biolegend Cat#406421), Donkey anti Rabbit IgG –Ax
647 (Biolegend Cat#406414), and Goat anti mouse IgG – Ax488 (Biolegend Cat#405315).
Dorsal Root Ganglia Dissociation- Prepared Collagenase IV (Sigma-Aldrich, C5138) enzyme
solution by added 3 mg of collagenase to 3 mL of HBSS (Ca2+/Mg2+ free). Enzymes were placed in
37C water bath. L2-L5 bilateral DRG were removed in less than 20 minutes. Aspirate all solution
from DRG solution and added 3mL of Collagenase IV solution via 0.2-micron filter. Incubated in a
37C incubator for 20 minutes. Centrifuge at 150g for 2 minutes, remove all media, cells were
reconstituted in 1 mL of HBSS (Ca2+/Mg2+ free) pH 7.2. DRG’s were triturated and pipetted through
70 m filter.
Flow Cytometry- Macrophages were isolated from naïve animals L2-L5 bilateral dorsal root ganglia.
Rapidly dissociated as previously described. Cells were suspended in a 1% BSA in PBS solution with
Fc Blocked (Biolegend Cat# 101310) for 30 minutes at 4C. Cells were spun down at 300g for 4
minutes and Fc block solution removed. Cells were re-suspended in 100ul of 1% BSA in PBS solution
and stained with pre conjugated antibodies against the following extra cellular proteins, CD11b-V450
(BD Bioscience Cat# 560455), CD39- PE (Biolegend Cat# 143804), MHC Class II- APC-Cy7
(Biolegend Cat#107628), LY6G-PE Tex Red (Biolegend Cat#127648), LY6C-BV570 (Biolegend,
Cat#128029), CCR2-APC (Biolegend Cat# 150604), CD11c-Percp (Biolegend, Cat# 117326),
CD103-Ax647 (Biolegend Cat# 121410), CD169-Ax488 (Cat# 42419), F4/80 –Percp (Cat# 123125)
and CX3CR1-PE Cy 7 (Biolegend, Cat#149016). Cells were gated for lives cells using FSC-A and
SSC-A parameters and further gated for singlet’s through SSC-A to SSC-H 1:1 ratio. Leukocyte
populations were identified through back gating CD11b(+) population.
Sciatic Nerve Crush- Sciatic nerve crush (SNC) was done as described. Briefly, mice were
anesthetized by inhalation of isoflurane (4% for induction and 3% for maintenance) in 100% O2. The
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left flank was shaved with surgical clippers and cleaned once with betadine solution. A small incision
was made in the mid-thigh region of the left leg. The inner muscle was separated using forceps to
expose the sciatic nerve. Using fine hemostatic forceps, the sciatic nerve was lifted out of the muscle
with care taken not to stretch the nerve. The nerve was crushed using one click of the hemostatic
forceps for 30 seconds. The wound was irrigated with sterile saline, and closed using a 5-0 polyglactin
910 suture (Ethicon). Sham surgery was identical to the sciatic nerve crush surgery except that the
sciatic nerve was exposed but not manipulated in any way. After the surgery, all mice were
individually housed with food and water readily available.
Injection of Complete Freunds Adjuvant (CFA) - Mice were anesthetized by inhaled isoflurane.
Sterile syringe consisting of a 1:1 mixture of saline to CFA was used to inject 20 μl of CFA into the
globourous hind paw skin. Mice survived for up to 1 or 3 days’ post injection.
Bone Marrow Derived Macrophages – Acutely cultured bone marrow derived macrophages were
obtained from tibia and femura of naïve male C57Bl/6J mice. Immature bone marrow cells were
culture for 72 hours in L929 culture media to induce macrophage differentiation. Following 72 hour
rest period in L929 media cells were treated with Capsaicin and CFA.
Cytokine Assays- 3 Days following injection with either CFA or saline bilaterally into the hind paws,
C57Bl/6J male and female mice (n=4 per condition) bilateral L2-L5 DRG were rapidly dissected and
dissociated as previously described. Cells were plated for 16 hours in DMEM- High Glucose media
supplemented with 10% FBS, 30% L929 conditioned media, and gentamycin. Following incubation
for 16 hours’ supernatant was removed and spun down to remove any debris in media. Protease
inhibitors were added to the supernatant. Protein quantification was performed on all samples to
determine protein concentration. Cytokine assay was done as described by manufacturing protocol
(R&D, XL mouse Cytokine Array A).
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RESULTS.
2.1 Macrophages exist in DRG of naïve male and female C57Bl/6J and BALB/cJ mice
The expression of CD11b and Ly6G proteins within naive L2-L5 dorsal root ganglia of female and
male C57Bl/6J and BALBc/j mice was analyzed by flow cytometry. CD11b expressing cells were
found in both male and female C57Bl/6J naïve L2-L5 DRG (Figure 2.1 B). This finding was confirmed
in another mouse strain: male and female BALB/cJ mice also express CD11b+ cell population in L2L5 naïve DRG (Supplemental Figure). In order to exclude the possibility that the CD11b+ population
of cells found in mouse DRG may be a previously unidentified population of neutrophils, dissociated
DRG were prepared and stained simultaneously with CD11b and Ly6G, a definitive neutrophil marker.
Ly6G was found in an insignificant population of CD11b+ cells (< 1%) in L2-L5 DRG of either
C57Bl/6J male or female mice (Figure 2.5). Similarly, dendritic cells were ruled out by evaluating
expression of CD11c and CD103 within the sensory ganglia. Very small or no populations of CD11c
cells with co-expression of CD11b (<1%) were found in the sensory ganglia (Figure 2.1 C.).
2.2 CSF1R-eGFP reporter mice enable analysis of DRG macrophage morphology and localization
Csf1r-eGFP resident tissue macrophages in naïve DRG were obtained from collagenase digested L2L5 DRG and stained for CD11b. Co-expression of CD11b and CD115-eGFP was found in DRG
resident tissue macrophages and spinal cord with the majority (>95%) of CD11b cells co expressing
CD115 (Figure 2.2 B, C).
2.3-2.5 DRG macrophages localize surrounding neuronal cell bodies, independent of vasculature and
satellite glia
Immunohistochemistry was used to determine localization of macrophages within the naïve ganglia.
The limited ability to perform IHC staining with currently available anti-CD11b antibodies, which
target highly ex-vivo labile cell surface integrin’s normally only visible on in tact cells by flow
cytometry, distribution of resident tissue macrophages was ascertained by immunostaining L4 naïve
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DRG of CD115-eGFP mice. CD115 is the CSF1-R receptor expressed and required for survival of
macrophages. Naïve L4 DRG were isolated from male B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J mice.
After flow cytometry analysis revealed co-expression of CD115 and CD11b without concurrent
expression of Ly6G or CD11c in DRG macrophages, L4 DRG isolated from CD115-eGFP mice were
prepared and stained with IHC antibodies against PGP9.5 to identify morphology and position
proximal to neuronal cell bodies. A robust population of resident tissue macrophages in the dorsal root
ganglia was observed with ramified processes, with close proximity to neuronal cell bodies (Figure
2.3).
Significant satellite glial cell populations also exist within the dorsal root ganglia surrounding
neuronal cell bodies, thus, to exclude the possibility of glial expression of CD115 in the B6N.CgTg(Csf1r-EGFP)1Hume/J mouse line, naïve L4 DRG were stained for glial fibrillary acidic protein
(GFAP). Satellite glia were found to be exclusive of CD115+ cells (Figure 2.4 D).
Due to the highly vascular nature of the dorsal root ganglia, leukocytes may exist within the
vasculature and not as part of the DRG microenvironment; thus it is possible that residual blood
leukocytes may have been inadvertently captured at the time of analysis. To exclude this possibility,
CD31, which is platelet endothelial cell adhesion molecule and is expressed on endothelial cells, was
used to label blood vessels in naïve L4 DRG isolated from CD115 B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J
reporter line. CD115 expressing cells were found to be predominately exclusive of vasculature in the
sensory ganglia (Figure 2.5 D).
2.6 Phenotypic analysis of DRG macrophages reveals a distinct population of tissue resident cells
The phenotype of CD11b+/Ly6G-/CD11c- macrophages isolated from naïve mouse DRG
resident tissue macrophage populations was analyzed by flow cytometry by staining with antibodies
directed against CX3CR1, MHC Class II, CD39, LY6C, CD169, and CCR2. DRG macrophages were
analyzed alongside blood monocytes and spinal microglia isolated from the same animal for
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comparison. A single cell suspension of whole dissociated DRG, red blood cell lysed blood leukocytes,
and dissociated lumbar spinal cord were prepared and stained prior to running the suspensions through
a BD LSRII flow cytometer. Analysis consisted of first sorting by size and granularity to identify a
live cell population consistent with macrophages, which are significantly smaller than neuronal cell
bodies and satellite glial cells but larger and more granular than lymphocytes. Samples were then gated
on CD11b+/Ly6G-/CD11c- cells where ‘gating’ refers to exclusion of all cells not found to express
CD11b or that do express Ly6G or Cd11c (hereafter referred to as DRG macrophages). CX3CR1 (CX3
chemokine receptor 1) was found to be highly expressed in majority (> 96%) of microglia and ~90%
DRG macrophages isolated from naïve animals (Figure 2.6 A, C). This high expression of CX3CR1
by DRG macrophages is a stark contrast to blood monocytes isolated from the same animals, in which
45-50% of blood monocytes express medium to low levels of CX3CR1 (Figure 2.6 B). The antigen
presentation molecule MHC Class II was found to be highly expressed on DRG resident tissue
macrophages (~90%) compared to microglia (~10%) and blood monocytes (~4%) (Figure 2.6 D, F).
Flow cytometric analysis of CD39 on resident tissue macrophages, microglia and blood
monocytes revealed that similar to microglia the majority of resident tissue macrophages in the DRG
have high expression of CD39, compared to blood monocytes which are CD39 low to null expressing
(Figure 2.6 G, H, I).
Low expression of LY6C in DRG resident tissue macrophages and microglia was found
compared to blood monocytes which have a higher overall expression of LY6C (Figure 2.6 J, K, L).
50% of resident tissue macrophages in the sensory ganglia expressed CCR2 compared to low to null
expression on microglia and approximately 25-30% of blood monocytes (Figure 2.6 M, N, O).
2.7 Sprague Dawley Rats express significant resident tissue macrophage population in naïve L2-L5
DRG.
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Macrophages isolated from female Sprague Daley rats were analyzed via flow cytometry.
Significant population of CD11b+, LY6G- populations were discovered (Figure 2.7 B, E). Thus
resident tissue macrophages are conserved across multiple species. Furthermore, these cells are
predominately MHC II positive similar to C57Bl/6J male and female mice (Figure 2.7 E).
2.8 Transient phenotypic changes induced by hind paw injection of CFA.
Marked upregulation of CD39 and MHC Class II was recorded in DRG resident tissue macrophages
24 hours following CFA injection (Figure 2.8 A, B, C) (n=4, *p< 0.05). Comparatively, no significant
changes in expression of CD39 or MHC Class II were observed in microglia isolated from the lumbar
enlargement of matched spinal cord (Figure 2.8 H, I, G). A significant increase in mid-level CD39
expressing blood monocytes was observed (Figure 2.8 D, F), although no concurrent increase in MHC
Class II was detected (Figure 2.8 E, F).
2.9 Evaluation of acutely cultured bone marrow derived macrophages treated with CFA and capsaicin
revealed no inducible change of CD39 of MHC II expression in treated cells. Differentiation of acutely
cultured bone marrow cells was established through cytokine induced induction of M1 and M2
macrophages. M1 differentiated cells markedly upregulated MHC Class II and iNOS where as M2
upregulated arginase (Figure 2.9 A-C). Following successful pro and trophic-inflammatory
polarization, differentiated cells were treated with high concentrations of CFA and Capsaicin at 100nm
or 100ng/mL of capsaicin or CFA, respectively. No notable changes in CD39 or MHC II expression
was seen in treated samples over control undifferentiated samples (n=3) (Figure 2.9 D-F).
2.10-2.11 Cytokine and Chemokine profile in L2-L5 C57Bl/6J DRG 3 days following CFA injection
Marked changes in the chemokine and cytokine profile of lumbar 2-5 DRG were observed 3 days
following intraplantar CFA injection in male and female C57Bl/6J mice. Sex dependence of cytokine
expression was variable: serepin-E1 was upregulated in both male and female mice following CFA
injection (Figure 2.10, 2.11). Furthermore, female specific upregulation of MMP3, a trophic cytokine,
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about 2 fold and pro inflammatory cytokines/chemokines CXCL2, CCL2, and CD14 in CFA treated
animals. Down regulation of IFN- in female CFA treated animals 72 hours post CFA injection
indicate a dynamic cytokine milieu following injury.
Similarly, males also exhibited biphasic cytokine response with both pro and trophic mediators
expressed 3 days following peripheral injury with CFA. Stark down regulation of MMP3 in CFA
treated animals was contrasted with upregulation of IL-13 and IL-4 in CFA treated mice. Pro
inflammatory cytokines, IL-1a, IL-1ra and CD14 were significantly upregulated in CFA treated mice
over saline treated. CCL2, an important chemokine in chemotaxis of leukocytes to injury was down
regulated in male CFA animals.
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Figure 2.1
Significant CD11b + cell populations are found within naïve L2-L5 DRG. Resident tissue macrophages
in naïve DRG were obtained from collagenase digested L2-L5 DRG and stained for CD11b. Both
C57Bl/6J male and female mice contain significant CD11b+ cell populations in naïve animals(
A,D,G,). Minimal neutrophil populations were identified as seen by minimal to no Ly6G expression
of CD11b+ cells (B,H), and dendritic cells CD11c (C,I) in DRG macrophages and microglia.
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A. Blood

B. DRG

C. Spinal Cord

Figure 2.2. CSF1R-eGFP reporter mice enable analysis of DRG macrophage morphology and
localization. Resident tissue macrophages in naïve DRG were obtained from collagenase digested L2L5 DRG in CD115-eGFP transgenic reporter mouse and stained for CD11b (B). Additionally, blood
monocytes (A), and spinal cord microglia (C) were isolated and stained against CD11b.
Coexpression of Cd11b and eGFP was seen in a majority of CD11b+ cells.
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Figure 2.3
L4 DRG section from a naive male mouse expressing eGFP (green) driven by the CSF1R promoter.
Double-labeling with antibodies to the neuronal marker PGP9.5 (red) indicates the presence of many
eGFP-positive cells closely apposed to neuronal cell bodies.
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Figure 2.4
Spatial arrangement of CD115-eGFP cells (green) around neuronal cell bodies (red) and GFAP+ cells
(blue) indicate absence of co localization between satellite glial cells (GFAP+) and immune cells
(CD115 +). A. neurons (red, Ax 647), B. satellite glial cells (blue, Cy3), C. CD115+ cells (green,
eGFP) and merged (D) within L4 naïve DRG.
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Figure 2.5
Immunostaining in L4 DRG with monoclonal antibodies against A. CD31 vasculature (PECAM) B.
Neuronal specific enolase (NSE), C. CD115-EGFP (+). Localization of all three markers (D) indicate
immune cells are exclusive of vasculature.
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Figure 2.6
L2-L5 DRG, blood, and lumbar enlargement of spinal cord were isolated from a naïve female
C57Bl/6J mouse and stained with indicated markers. Graphs represent Ly6G-CD11b+ macrophages
stained for CX3CR1 (a-c), MHC Class II (d-f), CD39 (g-i), Ly6C (j-l), and CCR2 (m-o).
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Figure 2.7
Blood, DRG and Spinal Cord were collected from naïve Sprague Dawley male rats by cardiac puncture
and dissection, respectively. All tissues were stained with antibodies against CD11b, Ly6G, and MHC
II. Graphs (A, B, C) were gated on live, singlet cells determined by forward and side scatter analysis.
Graphs (D, E, and F) were gated on CD11b+, Ly6G- cells.
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Figure 2.8
Up regulation of CD39 and MHC II on CD11b + Ly6G – mononuclear cells following CFA injection
in L2-L5 murine DRG in male C57Bl/6J mice. Specific upregulation of MHC II on DRG resident
tissue macrophages (c). No significant upregulation of MHC II on blood monocytes or microglia (f,
i). Fold change calculated by percent of cells in gate, *, p <0.05.
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Figure 2.9
Bone marrow was isolated from femora and tibiae of female wildtype C57Bl/6J mice and cultured. AC: Undifferentiated (grey), M1 (blue) or M2 (green) macrophages were induced. Control
differentiation (a, b, c) expression changes in M1 marker iNOS and M2 marker arginase are shown
for reference. D-F: Capsaicin 100nm (blue) or CFA 10ng/mL (green) was added to undifferentiated
culture and levels of iNOS, arginase and CD39 were measured after 24 hours.
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Figure 2.10
3 Days post either bilateral CFA injection or saline in the hind paws, C57Bl/6J female L2-L5 DRG
were rapidly dissected and dissociated into culture media. Cells were cultured for 16 hours.
Chemokine and cytokine production were evaluated from both saline(Grey) and CFA treated
mice(Blue). n=4, * p< 0.05, two tailed student’s t –test.
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Figure 2.11
3 Days post either bilateral CFA injection or saline in the hind paws, C57Bl/6J male L2-L5 DRG were
rapidly dissected and dissociated into culture media. Cells were cultured for 16 hours. Chemokine and
cytokine production were evaluated from both saline(Grey) and CFA treated mice (Blue). n=4,
*
p< 0.05, two tailed student’s t –test.
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CHAPTER 3
DISCUSSION
Studies show that nearly 100 million people suffer from chronic pain in the U.S. today [1].
Current therapies to treat pain, including opioids and NSAIDS, come with undesired side effects and
often fail to provide lasting benefits. Understanding the basic mechanisms of pain in the ascending
pathway and novel interactions between neurons and surrounding cells in the sensory ganglia is the
first step to designing and implementing novel therapies.
Here we have shown that not only do significant macrophage populations exist in naïve sensory
ganglia but they actively respond to neuronal stimulus. Naïve populations of resident tissue
macrophages represent, phenotypically a hybrid of microglia and blood monocytes, expressing similar
phenotypes distinct to both cell types. Thus, these cells may respond in similar but highly specialized
manner to cellular changes in the dorsal root ganglia microenvironment.
The data presented here suggest that DRG macrophages have evolved to patrol and interact
within the unique environment of the dorsal root ganglia. It is possible that the lack of blood brain
barrier protection in DRG contributes to the phenotype of macrophages expressed in naïve and injured
conditions. High expression of MHC Class II may provide ongoing antigen recognition ability
required to protect neuronal cell bodies. Exposure of cells within DRG to pathogens and systemic
cytokines is compounded by the highly vascular nature of the dorsal root ganglia, thus elevated
patrolling and monitoring of pathogens may be warranted for neuronal protection. Furthermore, MHC
Class II has been widely associated with pro inflammatory states of macrophages, suggesting that the
primarily M2 characteristic macrophages we describe in naïve DRG may be primed for rapid
conversion to M1 inflammatory macrophage activity under pathological conditions. The functional
state of DRG macrophages may play a role in persistent pain development as evidenced by our data
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showing rapid upregulation of MHC II and CD39 in the lumbar dorsal root ganglia following
intraplantar injection.
Persistent pain may arise from aberrant continual inflammatory input, thus understanding the
complex milieu of cytokine and chemokines in the dorsal root ganglia following peripheral injury may
illuminate inflammatory mechanisms of persistent pain. Here we have shown distinct cytokine
regulation in male and female mice following CFA injection in the hind paw. Interestingly, the
cytokine milieu consists of both pro and trophic- inflammatory signals in both sexes indicating a
complex immune response network. We hypothesize a biphasic response in which initial pro
inflammatory cytokines are supplanted by trophic-inflammatory cytokines as normal inflammatory
response dies down. To confirm, these experiments will need to be repeated in neuropathic pain injury
models. Our data indicate that in the time course of resolution, 3 days following CFA injection mice
exhibit peak pain behaviors. Thus, the 3-day time point may be a turning point where both pro- and
trophic inflammatory functions coincide. A complete time course will need to be completed to resolve
overlapping immune response questions.
A consistent upregulation of serepin E1 was noted in both male and female CFA treated
animals. We hypothesis that this finding may be indicative of a neuronal protective adaption by
macrophages in which they reduce scar tissue formation following injury. Serepin E1 inhibits
urokinase-type plasminogen activator (uPA) and tissue-type PA (1, 2) which both play a role in
angiogenesis and extracellular matrix remodeling [88]. Thus macrophages may initiate a neuronal
protective mechanism, by inhibiting scar tissue formation with the production and release of serpin
E1 following peripheral injury. Further studies such as investigation of fibrin and extra cellular
matrix remodeling following peripheral injury may further evaluate the role this may play in
neuronal plasticity and pain processing.
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Communication between neuronal cell bodies and resident tissue macrophages may occur,
especially under times of intense DRG neuronal stimulus, such as following distant injury or chronic
pain states. To this end ectonucleotidase triphosphate diphosphohydrolase-1, CD39, hydrolyzes
purinergic receptor ligands in specific P2 receptors ligands such as ATP. Neuronal expression of
purinergic receptors able to respond to ATP and AMP the substrate and product of CD39 indicate a
potential mechanism of communication between neurons and macrophages [62]. High naïve
expression as well as upregulation following peripheral insult (CFA) indicate this potential
communication mechanism is altered under pathological states and may provide an effect therapeutic
target to further alleviate pain states.
Modulation of ATP to AMP by CD39, provides the substrate for subsequent enzymes such as
CD73 which hydrolyze AMP to adenosine [62]. Adenosine has been implicated in numerous
mechanisms of pain processing [86]. Receptors on sensory neurons such as A2AR have been shown to
exhibit pro-nociceptive properties and may be activated by ligand production from resident tissue
macrophages [87]. Thus regulation of purinergic ligands in the extracellular milieu by macrophages
may impact pain processing and be a potential therapeutic target. Further pharmacological studies
inhibiting CD39 will be needed to elucidate the therapeutic potential of anti-CD39 therapies.
Future studies involve macrophage response to purinergic receptor ligands, looking for
calcium influx changes in the cell. Furthermore, identifying phosphorylation changes in macrophage
following ATP exposure, will help elucidate the intracellular signaling cascade that may drive
phenotypic as well as functional changes in resident tissue macrophages. Additionally, we hope to
evaluate human DRG macrophages and acutely culture isolated macrophages form human tissue
samples. Comparing human DRG macrophages to data collected in mice and rats will support or reveal
limitations of these findings to human pain processing.
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Our findings suggest not only is there a significant population of resident tissue macrophages
in the dorsal root ganglia but they are able to respond to distant insult with rapid phenotypic changes.
Given the severe lack of treatment modalities for persistent pain, these discoveries may aid in the
identification of therapeutic targets as well as our general knowledge of the pathological mechanisms
of persistent pain.
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CHAPTER 4

PREAMBLE- The following chapter will be written in a narrative as it outlines the struggles as well
as other preliminary data collected during my time in the lab.
APPENDIX DATA
METHODS
von Frey- Tactile sensory thresholds were determined by applying von Frey filaments (North Coast
Medical, CA) to the plantar surface of the left hind paw and recording the withdrawal response using
the up-down method (Dixon, 1980). Mice were placed in a clear Plexiglas chamber with a wire mesh
floor and allowed to habituate for 1 hour. Testing was conducted using filament sizes with respective
bending gram forces of 0.04, 0.07, 0.16, 0.4, 1.0, 2.0 and 4.0, starting filament = 0.4 g. Filaments were
pressed upward into the soft spot of the left hind paw until the filament was bent in half for a duration
of 5 seconds. A response was recorded if the mouse expressed a lifting, shaking or licking behavior
toward the hind paw during the application of the filament.
Hargreaves - Thermal sensory thresholds were determined by assessing the latency of each mouse to
respond to a noxious radiant heat source (Plantar Test, Ugo Basile, Italy; IR set to 28) (Hargreaves et
al., 1988). Following a 60-minute habituation period, the heat source was positioned directly beneath
the left hind paw to obtain withdrawal latencies. A maximal cut-off of 30 seconds was utilized to
prevent tissue damage.
Cell Fractionation – Cells were centrifuged at 150g for 5 minutes and supernatant removed. Cells
were resuspended in 90 μl of HBSS (Ca2+/Mg2+ free) pH 7.2 with 10 μl of CD11b (Miltenyi Biotec)
microbeads and placed on ice for 15 minutes. Added 2 mL of buffer (HBSS- Ca2+/Mg2+ free with 0.5%
BSA) to cell suspension. Centrifuged cell suspension at 150Xg for 5 minutes. Aspirated supernatant
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completely. Resuspended cell pellet in 500 uL of buffer (HBSS- Ca2+/Mg2+ free with 0.5% BSA).
Fractionated cells through large cell column (MACS) in HBSS- Ca2+/Mg2+ free with 0.5% BSA.
Unlabeled cells were further fractionated into neuronal and non-neuronal preparations.
Percoll Gradient- Rapidly dissociated dorsal root ganglia were placed in 37% Percoll in 1x PBS and
layered in a 15 mL conical tube with 2mLs of 70% Percoll, layered with 2 mLs of 37% Percoll with
cells, followed by 2 mLs of 30% Percoll solution then 2mLs of HBSS. Centrifuge at RT for 30 minutes
at 1760 rpm with no break on centrifuge. Harvest the 37/70 interface (mononuclear immune cells).
Transfer into fresh culture media.

Culture of human blood monocytes- Healthy monocyte differentiation assays: Peripheral Blood
Mononuclear Cells (PBMCs) were isolated from whole blood by Ficoll-Paque gradient (GE
Healthcare). Cells were cultured in a 5% CO2 incubator at 37 C in RPMI 1640 media supplemented
with Gentamicin (8ug/ml) Penicillin /Streptomycin (100 UI/ml), human macrophage colony
stimulating factor (M-CSF 20ng/ml), and 2.5% human plasma (from the PBMC donor) or 10% FBS.
4 hrs. Post seeding all media was changed in all wells removing all floating cells. At 3 days following
monocyte isolation 50% of the cell culture media will be replaced per day. On day 5, macrophage
differentiation was initiated. Cultures will be incubated for 2 days with no stimulation to create
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undifferentiated controls; or either lipopolysaccharide (LPS 10ng/ml) and interferon gamma (50
ng/ml) - to induce an M1 inflammatory macrophage differentiation - or transforming growth factor
beta TGF-B (10 ng/ml) and interleukin 4 (IL-4 20 ng/ml) -for M2 trophic macrophage differentiation.
Day 7, differentiated macrophages were detached from culture plates with 20 minutes of cold
incubation and Versine buffer (0.02% EDTA) and gentle scraping.
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RESULTS.

To investigate a means to remove neuronal cells from the dorsal root ganglia dissociation, we
tried to use a Percoll gradient. Successful separation of mononuclear immune cells from myelin and
most neuronal cells was achieved but due to the time and stress on the cells during the Percoll protocol
many if not all macrophages exhibited autoflorescences (Figure 5.1). We subsequently tried to bead
sort using Miltenyl Bead Sorting with pre conjugated magnetic beads against Cd11b (Cat#130-049601) however cell yield was low and only ~50% of cells survive the separation.
In addition to the above data we also collected information about the infiltration of neutrophils
and macrophages into the dorsal root ganglia following peripheral injury. To this end, we found a
decreased number of neutrophils and macrophages in the DRG following CFA administration (Figure
4.2). Contrary elevated levels as expected were found in the blood of the animals following intraplantar
injections of CFA.
Understanding the pathology of human dorsal root ganglia macrophages may be difficult as
human samples require facilities and set ups that allow seamless transfer of the tissue in a timely
fashion from the donor patient to the researcher. However, human isolated monocytes from leukopacs
may give the first insight to possible interactions of resident tissue macrophages in the dorsal root
ganglia of humans. Here we successfully isolated human monocytes from healthy donor blood and
differentiated them into trophic and pro inflammatory types (Figure 5.3).
In an effort to explore novel therapeutics, CB2 agonist Gp1a was administered to mice
following CFA injection. Behavioral testing indicated systemic (IP) injection of Gp1a during chronic
pain states may attenuate pain more rapidly than saline treated counter parts (Figure 5.4).
The pain input of macrophages is still widely unknown; here we deplete resident tissue
macrophages in ITGAM-DTR/EGFP female mice prior to CFA injection to understand the pain
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behaviors of DRG resident tissue macrophage depleted mice. ITGAM-DTR-EGFP mice demonstrated
a resistance to thermal pain as seen by a lack of hypersensitivity to IR behavioral tests (Figure 5.5).
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Figure 4.1
Flow Cytometry of naïve male CD115-Egfp, L2-L5 DRG following dissociation and Percoll gradient
separation, all graphs gated on live singlet cells (a) Cd11b+ cells (b) Ly6G+ cells.
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Figure 4.2
24 hours following intraplantar injection of either saline or CFA, female C57/B6N, L2-L5 DRG were
rapidly dissected and dissociated and stained with various macrophage and neutrophil markers.
CD115+CD11b+Ly6G- tissue resident macrophages unregulated CD39 (a) where grey histograms
represent saline treated animals and teal CFA treated. Macrophage and Neutrophil percent of total
CD115 cells reported in DRG.
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Figure 4.3
Human macrophages were acutely cultured from human leukopacs. Top Row: Acutely cultured
macrophages express CD11b and CD14 traditional macrophage lineage markers (A, B).
Undifferentiated (grey), M1 (blue) or M2 (green) macrophages were induced. Control differentiation
(C, D) expression changes in M1 marker HLA-DR and M2 marker CD206 are shown for reference.

60

% activity Von Frey

125

125

100

100
75
50
25
0

% activity I.R.

150

% Activity ( ± SEM)

% Activity ( ± SEM)

150

75
50
25
0

Baseline

24 Hrs

4 Days

9 Days

Baseline

24 Hrs

4 Days

9 Days

Time post-CFA

Time post-CFA
Vehicle

6 mg/kg GP 1a

Figure 4.4
Von Frey and IR analysis of mice treated with GP 1a, a CB2 receptor agonist. Wild-type C57Bl6/J
female mice were baselined prior to hind paw injection with Complete Freund’s Adjuvant (CFA) and
intraperitoneal injection of 6mg/kg GP 1a or vehicle. Analyses were repeated at various points
throughout the inflammatory state.
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Figure 4.5
CD11b+ cells were depleted in ITGAM-DTR/EGFP female mice via DTx injection. 24 hours postmacrophage depletion, mice received hind paw injection with CFA and subjected to von Frey/IR
analysis at several time points and compared to wild-type.

DISCUSSION OF APPENDIX DATA
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Here our results show that Percoll separation does eliminate significant neuronal contamination
as well as myelin from the DRG tissue preparation. However, the limited resident tissue macrophages
isolated from the mouse lumbar ganglia limits the ability to successfully culture pure macrophage
cultures, limiting the scope of our studies currently.
When evaluating the neutrophil and CD11b overall population in the dorsal root ganglia we
saw a reduction of CD11b and Ly6G positive cells in the DRG whereas the blood saw a noticeable
increase. This may be the result of activated immune cells tracking out of the dorsal root ganglia
following injury, further supported by the high expression of the antigen presentation protein MHC
Class II which may drive the cells to migrate to lymph nodes following injury to initiate an adaptive
immune response. However further studies understanding the infiltration of blood monocytes and
proliferation of resident tissue macrophages in response to injury is needed.
Human studies have also proven hard to conduct due to the limited access to fresh non fixed
human dorsal root ganglia. Here we attempt to isolate blood monocytes from human leukopacs and
differentiate them into pro or trophic states. Here we were able to establish an isolation and culture
protocol of human blood monocytes as well as successfully differentiate these cells into a pro and
trophic state as seen by marked upregulation of CD206 and HLA-DR (MHC Class II) on CD14+
human macrophages. Using human isolated macrophages, we can further begin to understand the
potential response of DRG macrophages in human pain processing and their response to various
purinergic agonist.
Presently, a small body of evidence suggests the existence of resident DRG macrophages and
their phenotypic changes following insult. Supporting a link between macrophages and inflammatory
pain, studies demonstrate that cannabinoid receptor type 2 (CB2) agonists attenuate pain in acute,
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chronic, neuropathic, and inflammatory states and suppress pro-inflammatory cytokine release.
Additional studies suggest macrophage activity is altered by CB2 activation.
Our findings suggest an analgesic effect following systemic GP 1a administration in a mouse
model of inflammatory pain as well as diminished CFA-induced hypersensitivity in macrophagedepleted mice. More studies should be conducted to confirm these findings and determine if DRG
macrophages undergo phenotypic changes in response to insult or CB2 agonists. These data will be
critical for determining the role of DRG macrophages in nociceptor remodeling and sensitization. The
results of future studies may lead to the development of novel therapeutic approaches for the
management of inflammatory pain.
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MATERIALS USED.
GENE

Forward Primer

Reverse Primer

CD11b

5’-TTACGTAGCGAATGACCCCT-3’

5’-GTTTCACAAAACCAATGGGG-3’

CD39

5’-TCAGTCCCACAGCAATCAAA-3’

5’-ACGAGGGAAGAGGAAGGAAA-3’

CD115

5’-AGGGCAACTGAGTAGGGTCA-3’

5’-CTCTGCTGGTGCTACTGCTG-3’

CD163

5’TGTATGCCCTTCCTGGAGTC-3’

5’-TGTGCAGTGTCCAAAAGGAG-3’

Arginase-1

5’TTTTCCAGCAGACCAGCTTT-3’

5’-GGAACCCAGAGAGAGCATGA-3’

CCL-2

5’- ATTGGGATCATCTTGCTGGT-3’

5’- CCTGCTGTTCACAGTTGCC-3’

CSF-1

5’GGTAGTGGTGGATGTTCCCA-3’

5’CCAGGATGAGGACAGACAGG-3’
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